What is Agilent Technologies, Inc. (A) DCF Fair Value and Intrinsic Value in 2026?

Agilent Technologies, Inc. (A) intrinsic value is calculated using conservative multi-stage Discounted Cash Flow (DCF) models, 5-year free cash flow trajectories, Graham Numbers, and owner earnings multiples. LocalAlpha tracks real-time margin of safety against live market prices.

What is Agilent Technologies, Inc.'s historical Return on Invested Capital (ROIC) and Moat Rating?

Agilent Technologies, Inc. operates in the Healthcare sector (Diagnostics & Research) with an economic moat rating of WIDE. LocalAlpha tracks 5-year audited quarterly ROIC, operating margin stability, and balance sheet solvency ratios.

What is Agilent Technologies, Inc.'s financial health rating and Piotroski F-Score?

Agilent Technologies, Inc.'s balance sheet quality is evaluated using the 9-point Piotroski F-Score, Altman Z-Score solvency model, debt-to-equity ratio, and quick/current liquidity coverage to guard against financial distress.

How does LocalAlpha monitor Agilent Technologies, Inc. (A) for quarterly SEC filing thesis breaks?

LocalAlpha audits Agilent Technologies, Inc.'s 10-K, 10-Q, and 8-K regulatory filings on SEC EDGAR within 15 minutes of release. If reported metrics breach an investor's custom ROIC floor, operating margin boundary, or qualitative risk criteria, an autonomous breach audit is dispatched immediately.

StocksA

A

Agilent Technologies, Inc.Healthcare / Diagnostics & ResearchINTACT

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems. This segment is also involved in the genomics, contract development and manufacturing organization, pathology, companion diagnostics, and biomolecular analysis businesses. The Agilent CrossLab segment provides various services, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, consulting, and other custom services. This segment also offers consumables, including gas chromatography and liquid chromatography columns, sample preparation products, custom chemistries, and various laboratory supplies; software and informatics solutions comprising software for instrument control, data acquisition, data analysis, secure storage of results, and laboratory information and workflow management; and OpenLab laboratory software, an open software platform that enables customers to capture, analyze, and share scientific data throughout the lab and across the enterprise. In addition, it provides automated sample preparation solutions, such as liquid handling, plate management, consumables, and scheduling software. The Applied Markets segment offers products in the areas of gas chromatography, mass spectrometry, spectroscopy, vacuum technology, and remarketed instruments. It markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Share Price

$146.13

52W: $108.35 - $163.75

DCF Fair Value

$89.07

-64.1% Premium

Thesis Hub

P/E (TTM)

28.8x

ROIC

19.2%

Operating Margin

25.6%

FCF Yield

2.6%

Debt / Equity

0.56x

Piotroski Score

8/9

Altman Z-Score

3.19

Market Cap

$41.2B

Price vs. Intrinsic Value Corridor

Overvalued vs DCF ($89.07)

Historical market price overlaid against conservative DCF Fair Value & Benjamin Graham Margin of Safety bands.

Period Return (1Y)

—()

Period Range

$— - $—

DCF Fair Value

$89.07

MOS Buy Target (-25%)

$66.80

Valuation Overlays: DCF Fair Value ($89.07) 25% MOS Buy Target ($66.80) Revised Graham ($128.74) Graham Number ($54.58)

2-Stage Discounted Cash Flow (DCF) Workbench

Conservative intrinsic value model based on owner cash generation over a 10-year investment horizon. Opens with LocalAlpha's baseline assumptions (matching the fair value shown above) — adjust any input to stress-test.

Current Market Price

$146.13

DCF Fair Value

$89.37

-63.5% Premium

Starting Free Cash Flow ($M)$1,060M

$100M$1,060M (Reported)$50,000M

Stage 1 Growth (Years 1-5)12.8%

-5%10% (Target)35%

Stage 2 Growth (Years 6-10)4.5%

0%5%20%

Discount Rate (WACC / Hurdle)9.0%

6%9% (Standard)15% (High Risk)

Terminal Perpetual Growth2.5%

1% (GDP Floor)2.5% (Inflation)4.0%

Net Debt ($M)$2,300M

-$100B CashBalance Sheet+$150B Debt

10-Yr PV of Cash Flows

$11.4B

PV of Terminal Value

$16.1B

Implied Enterprise Value

$27.5B

Implied Equity Value

$25.2B

Year	Yr 1	Yr 2	Yr 3	Yr 4	Yr 5	Yr 6	Yr 7	Yr 8	Yr 9	Yr 10
Projected FCF ($M)	$1,196	$1,349	$1,521	$1,716	$1,936	$2,023	$2,114	$2,209	$2,308	$2,412
Present Value (PV)	$1,097	$1,135	$1,175	$1,216	$1,258	$1,206	$1,156	$1,109	$1,063	$1,019

Benjamin Graham & Buffett Value Models

Classical deep value metrics based on asset backing, normalized earnings power, and owner cash yield.

Graham Number-167.7% Premium

$54.58

Calculated as √(22.5 × EPS × BVPS). The maximum theoretical price a defensive investor should pay based purely on asset book value and current earnings.

EPS: $5.07BVPS: $26.11

Revised Graham Formula-13.5% Premium

$128.74

Formula: V = (EPS × (8.5 + 2g) × 4.4) / Y where g is the conservative 7-10 yr growth rate and Y is AAA Bond Yield.

Growth Rate (g%)

Bond Yield (Y%)

Buffett Owner Earnings2.4% Yield

$3.57 / share

True distributable cash flow: Net Income + D&A - Maintenance CapEx. Reflects the cash Buffett would extract without hurting unit volume.

Total: $1.0BYield: 2.4%

Reverse DCF: Market Growth Expectation

HIGH BARRIER

14.4% CAGR (Next 10 Yrs)

At the current price of $146.13, the market is assuming the business will compound Free Cash Flow at 14.4% per year for the next decade with a 9% hurdle rate.

Value Investor Verdict

ℹ Fair expectations: Requires steady execution.

Autonomous Thesis Underwriting

Surveil A with Mathematical Margin of Safety Rules

Set non-negotiable floor rules for Agilent Technologies, Inc.. If a newly filed quarterly 10-Q breaks your ROIC floor, operating margin boundary, or balance sheet leverage rules, receive an autonomous breach audit within 15 minutes.

Buffett Quality

ROIC > 15% • Margin > 15% • D/E < 0.5x

Margin Floor Guard

Current Margin 25.6% • Floor > 10%

Solvency Guard

Altman-Z > 2.6 • Current Ratio > 1.5x

Track A & Set Alerts Browse S&P 500 Coverage

Frequently Asked Questions: Agilent Technologies, Inc. (A) Intrinsic Valuation

Audited fundamentals, DCF intrinsic value sensitivity, and thesis break detection parameters for Agilent Technologies, Inc..

Based on institutional multi-stage Discounted Cash Flow (DCF) modeling on audited SEC cash flows, Agilent Technologies, Inc. has an estimated DCF intrinsic fair value of $89.07 per share compared to its current market price of $146.13. This represents an estimated 64.1% premium over fair value. Additionally, its classic Benjamin Graham Number stands at $54.58.